1. Home
  2. ORMP vs RVPH Comparison

ORMP vs RVPH Comparison

Compare ORMP & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • RVPH
  • Stock Information
  • Founded
  • ORMP 2002
  • RVPH 2006
  • Country
  • ORMP United States
  • RVPH United States
  • Employees
  • ORMP N/A
  • RVPH N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • RVPH Health Care
  • Exchange
  • ORMP Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • ORMP 90.7M
  • RVPH 88.0M
  • IPO Year
  • ORMP N/A
  • RVPH N/A
  • Fundamental
  • Price
  • ORMP $2.33
  • RVPH $1.68
  • Analyst Decision
  • ORMP Hold
  • RVPH Strong Buy
  • Analyst Count
  • ORMP 1
  • RVPH 5
  • Target Price
  • ORMP N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • ORMP 496.8K
  • RVPH 1.5M
  • Earning Date
  • ORMP 03-05-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • ORMP N/A
  • RVPH N/A
  • EPS Growth
  • ORMP N/A
  • RVPH N/A
  • EPS
  • ORMP 0.11
  • RVPH N/A
  • Revenue
  • ORMP N/A
  • RVPH N/A
  • Revenue This Year
  • ORMP N/A
  • RVPH N/A
  • Revenue Next Year
  • ORMP N/A
  • RVPH N/A
  • P/E Ratio
  • ORMP $21.65
  • RVPH N/A
  • Revenue Growth
  • ORMP N/A
  • RVPH N/A
  • 52 Week Low
  • ORMP $2.00
  • RVPH $0.60
  • 52 Week High
  • ORMP $3.67
  • RVPH $4.45
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 50.27
  • RVPH 40.29
  • Support Level
  • ORMP $2.16
  • RVPH $1.66
  • Resistance Level
  • ORMP $3.09
  • RVPH $1.88
  • Average True Range (ATR)
  • ORMP 0.15
  • RVPH 0.15
  • MACD
  • ORMP 0.02
  • RVPH -0.03
  • Stochastic Oscillator
  • ORMP 21.65
  • RVPH 4.08

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: